Combined targeting poly (ADP-ribose) polymerase and receptor tyrosine kinase inhibits ovarian clear cell carcinoma progression through disrupted ribosome biogenesis. [PDF]
J Mol Med (Berl)Lin CY +8 more
europepmc +1 more source
Poly(ADP-ribose) polymerase 1 orchestrates vascular smooth muscle cell homeostasis in arterial disease. [PDF]
Exp Mol MedXu W +9 more
europepmc +1 more source
Progesterone Enhances the Sensitivity of Ovarian Cancer Cells to Poly (ADP-Ribose) Polymerase (PARP) Inhibitors by Suggesting a Role for Transcription-Replication Conflict-Related Pathways: An In Vitro Study. [PDF]
CureusSuizu E +8 more
europepmc +1 more source
The poly (ADP-ribose) polymerase inhibitor olaparib attenuates established pulmonary fibrosis in a large animal model. [PDF]
BMC Pulm MedDerseh HB +8 more
europepmc +1 more source
Versatile Modular Antibodies for Sensitive and Specific Detection of Poly-ADP-Ribose
Dauben H, Matić I.
europepmc +1 more source
ELTA: Enzymatic Labeling of Terminal ADP-Ribose
Molecular Cell, 2019 ADP-ribosylation refers to the addition of one or more ADP-ribose groups onto proteins. The attached ADP-ribose monomers or polymers, commonly known as poly(ADP-ribose) (PAR), modulate the activities of the modified substrates or their binding affinities
Yoshinari Ando +2 more
exaly +3 more sources
Related searches:
Poly(ADP-ribose): A Dynamic Trigger for Biomolecular Condensate Formation
Trends in Cell Biology, 2020Anthony K L Leung
exaly
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Ca-A Cancer Journal for Clinicians, 2011Timothy A Yap +2 more
exaly
Role of poly(ADP-ribose) synthetase in inflammation and ischaemia–reperfusion
Trends in Pharmacological Sciences, 1998Csaba SZABÓ +2 more
exaly